2020
DOI: 10.1007/s40122-020-00173-5
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns

Abstract: Concern about the appropriate role of nonsteroidal anti-inflammatory drugs (NSAIDs) in COVID-19 speculate that NSAIDs, in particular ibuprofen, may upregulate the entry point for the virus, the angiotensin-converting enzyme (ACE) 2 receptors and increase susceptibility to the virus or worsen symptoms in existing disease. Adverse outcomes with COVID-19 have been linked to cytokine storm but the most effective way to address exaggerated inflammatory response is complex and unclear. The Expert Working Group on th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
42
0
5

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 42 publications
(47 citation statements)
references
References 24 publications
0
42
0
5
Order By: Relevance
“…NSAIDs, which have been concerned to upregulate ACE 2 receptors and to increase the susceptibility to the virus, 40 and glucocorticoids, which might negatively affect virus clearance, 41 should not automatically be stopped in patients with RMDs according to the EULAR task force. 11 Even patients with symptoms of COVID-19 who are chronically treated with glucocorticoids should continue this treatment.…”
Section: Discussionmentioning
confidence: 99%
“…NSAIDs, which have been concerned to upregulate ACE 2 receptors and to increase the susceptibility to the virus, 40 and glucocorticoids, which might negatively affect virus clearance, 41 should not automatically be stopped in patients with RMDs according to the EULAR task force. 11 Even patients with symptoms of COVID-19 who are chronically treated with glucocorticoids should continue this treatment.…”
Section: Discussionmentioning
confidence: 99%
“…NSAIDs are relatively contraindicated in patients with respiratory disorders, as in acute respiratory infections. NSAIDs have also been implicated in acute myocardial infarction and risk of stroke in rare cases [25]. Specific concerns related to COVID-19 and the use of NSAIDs have hypothesized that NSAIDs may upregulate entry through the angiotensin-converting enzyme (ACE) 2 receptors, thereby increasing susceptibility to the virus.…”
Section: • Nsaidsmentioning
confidence: 99%
“…Specific concerns related to COVID-19 and the use of NSAIDs have hypothesized that NSAIDs may upregulate entry through the angiotensin-converting enzyme (ACE) 2 receptors, thereby increasing susceptibility to the virus. These data are still inconclusive [25]. Selective COX-2 inhibitors (e.g., etoricoxib and celecoxib) COX-2 inhibitors specifically target prostaglandins that mediate pain and inflammation and have less gastric side effects compared to their non-specific NSAID counterparts.…”
Section: • Nsaidsmentioning
confidence: 99%
See 2 more Smart Citations